Fig. 6AFrom: Prospective virtual screening combined with bio-molecular simulation enabled identification of new inhibitors for the KRAS drug target3D interactions of covalent inhibitors (A) standard drug- KRASG12C complex (B) SANC00905- KRASG12C (C) ZINC001458505494- KRASG12CBack to article page